JAK1 pathway inhibitors for the treatment of vitiligo Grant US-11957661-B2 United States of America 16 Apr 2024
Spirocyclic lactams as JAK2 V617F inhibitors Grant US-11958861-B2 United States of America 16 Apr 2024
Powerful MHC-class II peptides derived from survivin Grant US-11957729-B2 United States of America 16 Apr 2024